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Gifts to Physicians From Industry
To the Editor. \p=m-\Controversysurrounds
the relationship between the pharma-
ceutical industry and physicians.1-3 Con-
gressional hearings have focused on the
extravagant gifts that some physicians
have received from pharmaceutical
companies, implying that many physi-
cians routinely accept these gifts
(Am Med News. December 28, 1990).
Recently, the American Medical Asso-
ciation (AMA) published guidelines
stating that gifts to physicians are ac-
ceptable if they entail a benefit to pa-
tients and are of no substantial value.4
Gifts of minimal value are also accept-
able if they are related to the physician's
work.4 Despite these reports, there are
few data in the medical literature exam-
ining to what extent current pharma-
ceutical gift-giving behaviors may com-
plywith recent guidelines.
Exhibit hall gift promotions are a
common part of major medical meet-
ings. While attending a recent national
meeting of a major medical specialty, I
studied a selection of pharmaceutical
exhibits to determine the types and pro-
portions of free gifts that were being
distributed by exhibitors to physician
attendees. Exhibitors were inspected
once over a 3-day period. Eligible exhib¬
itors were restricted to those who
marketed prescription pharmaceutical
products. At each exhibit, I recorded
the name of the pharmaceutical compa¬
ny, its pharmaceutical products, and
any free promotional items on display.
Sixty-eight different prescription
pharmaceutical exhibitors were stud¬
ied, comprising 75% of all prescription
pharmaceutical product booths ex¬
hibited at the meeting (n = 92) and 55
separate pharmaceutical companies.
Ninety-one percent of all exhibitors sur¬
veyed distributed different types of free
promotional gift items, which are sum¬
marized in the Table.
The promotional gift tabulations are
likely to be conservative for several rea¬
sons. Many pharmaceutical exhibitors
distributed their more expensive exhib¬
it hall gift items only after a physician
had entered into a dialogue with the
Edited by Drummond Rennie, MD, Deputy Editor
(West), and Don Riesenberg, MD, Senior Editor.









Total 100 (n = 68)
*For example, pens, notepads, and penlights.
}As defined by American Medical Association guide¬
lines on drug industry gifts.
}For example, watches, clocks, games, tape record¬
ers, cameras, stuffed animals, and clothes.
pharmaceutical representative. Such
promotional items were usually kept
out of sight under an exhibit table. In
addition, several pharmaceutical com¬
panies distributed free tickets to enter¬
tainment events not occurring at the
exhibit hall. Neither of these types of
gift promotions was included in my
estimates.
The extent to which physicians accept
pharmaceutical gifts is unknown. How¬
ever, this study demonstrates that most
pharmaceutical exhibitors who market
prescription pharmaceutical products
distribute free promotional gift items to
attendees at medical meetings. Accord¬
ing to current AMA guidelines, at least
one third of these gifts might be consid¬
ered inappropriate since they are un¬
likely to provide direct benefit to the
patient and are of greater than min¬
imal value. Some researchers have sug¬
gested that physician acceptance of any
gifts from the pharmaceutical industry
is problematic because of the traditional
features of reciprocity implicit in all gift-
taking behaviors.5
My informal study suggests that the
extent of exhibit hall gift promotions
can be tracked and compared with ap¬
plicable guidelines. Further work is
needed to define the extent of pharma¬
ceutical gift promotions at all levels of
medical education, private practice, and
continuing medical education. Ulti¬
mately, such research should attempt to
define what effects such promotions
have on physician prescribing be¬
haviors, as well as the costs of prescrip¬
tion drugs for patients.
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To the Editor.\p=m-\TheCouncil on Ethical
and Judicial Affairs of the AMA1 has
taken an important step toward clarify-
ing the relationship between the medi-
cal service industry and physicians. Un-
fortunately, it is neglecting an im-
portant area of concern.
Many university facultymembers and
prominent practicing physicians serve
as paid consultants to major pharma-
ceutical houses and travel around the
country giving seminars and education-
al conferences that are frequently, al-
though not always, thinly veiled promo-
tions for particular products. In doing
so, they exercise their rights as individ-
uals to contract for services, but they
also abrogate their responsibilities as
faculty members to pursue an impartial
view ofmedical research and therapy.
When they become agents of indus-
try, they should be barred from serving
on anymajor university or hospital com-
mittees that might cause a conflict of
interest, such as pharmacy and thera-
peutics committees and committees
that set standards of care or practice
guidelines or allocate public research
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